PROCEPT BioRobotics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for PROCEPT BioRobotics Corporation (PRCT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-91.41-105.90-87.15-59.85-53.02
Depreciation & Amortization5.233.812.843.322.86
Stock Based Compensation31.8419.1310.343.802.17
Change in Working Capital-47.33-26.16-11.49-4.71-0.48
Change in Accounts Receivable-35.96-33.10-10.81-2.91-0.51
Change in Inventory-17.24-9.75-15.25-6.12-3.11
Change in Accounts Payable-2.155.793.960.81-0.21
Change in Other Working Capital8.027.591.482.733.21
Other Operating Activities2.451.121.480.110.13
Net Cash from Operating Activities-99.21-108.00-80.38-57.33-48.34
Investing Activities
Capital Expenditures-4.41-25.21-2.65-0.59-0.23
Net Cash from Investing Activities-4.41-25.21-2.65-0.59-0.23
Financing Activities
Debt Repayment0.000.00-50.000.000.00
Common Stock Issued164.52167.806.42176.552.29
Other Financing Activities15.600.00-4.000.000.00
Net Cash from Financing Activities180.13167.803.61262.12106.77
Summary
Net Change in Cash76.5034.59-79.42204.1958.20
Cash at Beginning of Period260.26225.67305.10100.910.00
Cash at End of Period336.76260.26225.67305.100.00
Free Cash Flow-103.62-133.21-83.04-57.93-48.58
Supplemental Disclosures
Interest Paid3.974.064.294.753.97